scholarly article | Q13442814 |
P356 | DOI | 10.1016/0006-291X(86)90736-9 |
P698 | PubMed publication ID | 3778479 |
P2093 | author name string | Nagai Y | |
Kamata Y | |||
Sakaguchi G | |||
Iwamori M | |||
Kozaki S | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
Clostridium botulinum | Q131268 | ||
P304 | page(s) | 1015-1019 | |
P577 | publication date | 1986-11-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids | |
P478 | volume | 140 |
Q35467723 | Anti-GT1a IgG in Guillain-Barré syndrome. |
Q40160930 | Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids |
Q48662400 | Binding of Botulinum and Tetanus Neurotoxins to Ganglioside GT1b and Derivatives Thereof |
Q46663715 | Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins |
Q33869062 | Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors |
Q36099792 | Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH |
Q42835857 | Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes |
Q35932883 | Glycosphingolipids-sweets for botulinum neurotoxin |
Q36992893 | Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. |
Q42858035 | Interaction of botulinum and tetanus toxins with the lipid bilayer surface |
Q47877385 | Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? |
Q38252747 | Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes |
Q38117277 | Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome |
Q37843686 | Receptor mimicry as novel therapeutic treatment for biothreat agents |
Q41082871 | Structure and function of tetanus and botulinum neurotoxins. |
Q48026258 | Two Feet on the Membrane: Uptake of Clostridial Neurotoxins |
Q57808978 | Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics |
Search more.